ProterixBio, Inc. will be attending the Respiratory Innovation Summit at the American Thoracic Society Conference, to be held May 19, 2018 at the Manchester Grand Hyatt, San Diego, CA. The Respiratory Innovation Summit unites the innovators, investors and clinicians who are leading the fight to create powerful new treatments for deadly and crippling diseases of the lungs and airways.
Michael F. Miller, Ph.D., president and chief executive officer of ProterixBio, will speak at the conference. His presentation will highlight ProterixBio’s advanced molecular assessments to improve care and accelerate therapeutics development for patients with chronic respiratory diseases. The company’s first product is focused on COPD (chronic obstructive pulmonary disease) which is a leading cause of death and contributor to health care spending worldwide.
For more information: